Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
23
VTIAF Quote, Financials, Valuation and Earnings
Last price:
$6.38
Seasonality move
:
0%
Day range:
$6.38 - $6.38
52-week range:
$4.52 - $9.00
Dividend yield:
0%
P/E ratio:
39.49x
P/S ratio:
1.14x
P/B ratio:
6.87x
Volume:
--
Avg. volume:
4
1-year change:
41.04%
Market cap:
$111.1M
Revenue:
$88.9M
EPS (TTM):
-$0.59
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
VTIAF
FamiCord AG
|
-- | -- | -- | -- | -- |
|
BNTX
BioNTech SE
|
$964.2M | -$0.07 | -24.04% | -86.85% | $138.33 |
|
CVAC
CureVac NV
|
$15.4M | -$0.11 | 0.04% | -32.36% | $5.31 |
|
EVO
Evotec SE
|
$278M | -$0.01 | 17.8% | -75.1% | $5.4436 |
|
IFRX
InflaRx NV
|
$30.8K | -$0.16 | -74.55% | -16.09% | $11.25 |
|
IMTX
Immatics NV
|
$10.9M | -$0.47 | -81.87% | -704.25% | $18.75 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
VTIAF
FamiCord AG
|
$6.38 | -- | $111.1M | 39.49x | $0.00 | 0% | 1.14x |
|
BNTX
BioNTech SE
|
$95.20 | $138.33 | $22.9B | 191.55x | $0.00 | 0% | 6.48x |
|
CVAC
CureVac NV
|
$4.52 | $5.31 | $1B | 6.33x | $0.00 | 0% | 12.56x |
|
EVO
Evotec SE
|
$3.0800 | $5.4436 | $1.1B | -- | $0.00 | 0% | 1.31x |
|
IFRX
InflaRx NV
|
$1.01 | $11.25 | $68.4M | -- | $0.00 | 0% | 312.07x |
|
IMTX
Immatics NV
|
$10.50 | $18.75 | $1.3B | 42.21x | $0.00 | 0% | 14.03x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
VTIAF
FamiCord AG
|
58.43% | 0.709 | 19.05% | 0.55x |
|
BNTX
BioNTech SE
|
1.31% | 1.387 | 1.22% | 6.78x |
|
CVAC
CureVac NV
|
3.87% | 2.758 | 3.39% | 1.84x |
|
EVO
Evotec SE
|
37.72% | 1.403 | 44.12% | 1.05x |
|
IFRX
InflaRx NV
|
2.1% | -0.265 | 1.26% | 2.34x |
|
IMTX
Immatics NV
|
3.78% | 1.667 | 1.86% | 6.97x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
VTIAF
FamiCord AG
|
$11.4M | $1.5M | -27.19% | -62.13% | 5.52% | $1.7M |
|
BNTX
BioNTech SE
|
$1.6B | $743.4M | -2.96% | -3.01% | 41.89% | $785.5M |
|
CVAC
CureVac NV
|
$57.9M | -$11.6M | 19.52% | 20.55% | -18.33% | $31.6M |
|
EVO
Evotec SE
|
-$72.4K | -$59.7M | -11.62% | -17.7% | -31.17% | -$101.3M |
|
IFRX
InflaRx NV
|
-$89.2K | -$11.7M | -80.95% | -82.01% | -42057.91% | -$11.4M |
|
IMTX
Immatics NV
|
-- | -$63.9M | -24.18% | -25.21% | -1053.82% | -$56.2M |
FamiCord AG vs. Competitors
-
Which has Higher Returns VTIAF or BNTX?
BioNTech SE has a net margin of 5.38% compared to FamiCord AG's net margin of -1.89%. FamiCord AG's return on equity of -62.13% beat BioNTech SE's return on equity of -3.01%.
Company Gross Margin Earnings Per Share Invested Capital VTIAFFamiCord AG42.89% $0.08 $37.1M BNTXBioNTech SE90.24% -$0.14 $22B -
What do Analysts Say About VTIAF or BNTX?
FamiCord AG has a consensus price target of --, signalling downside risk potential of --. On the other hand BioNTech SE has an analysts' consensus of $138.33 which suggests that it could grow by 45.31%. Given that BioNTech SE has higher upside potential than FamiCord AG, analysts believe BioNTech SE is more attractive than FamiCord AG.
Company Buy Ratings Hold Ratings Sell Ratings VTIAFFamiCord AG0 0 0 BNTXBioNTech SE14 5 0 -
Is VTIAF or BNTX More Risky?
FamiCord AG has a beta of 0.475, which suggesting that the stock is 52.494% less volatile than S&P 500. In comparison BioNTech SE has a beta of 1.393, suggesting its more volatile than the S&P 500 by 39.311%.
-
Which is a Better Dividend Stock VTIAF or BNTX?
FamiCord AG has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. BioNTech SE offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. FamiCord AG pays 0.02% of its earnings as a dividend. BioNTech SE pays out -- of its earnings as a dividend. FamiCord AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios VTIAF or BNTX?
FamiCord AG quarterly revenues are $26.6M, which are smaller than BioNTech SE quarterly revenues of $1.8B. FamiCord AG's net income of $1.4M is higher than BioNTech SE's net income of -$33.5M. Notably, FamiCord AG's price-to-earnings ratio is 39.49x while BioNTech SE's PE ratio is 191.55x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for FamiCord AG is 1.14x versus 6.48x for BioNTech SE. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income VTIAFFamiCord AG1.14x 39.49x $26.6M $1.4M BNTXBioNTech SE6.48x 191.55x $1.8B -$33.5M
-
Which has Higher Returns VTIAF or CVAC?
CureVac NV has a net margin of 5.38% compared to FamiCord AG's net margin of -5832.47%. FamiCord AG's return on equity of -62.13% beat CureVac NV's return on equity of 20.55%.
Company Gross Margin Earnings Per Share Invested Capital VTIAFFamiCord AG42.89% $0.08 $37.1M CVACCureVac NV91.57% $1.41 $1.1B -
What do Analysts Say About VTIAF or CVAC?
FamiCord AG has a consensus price target of --, signalling downside risk potential of --. On the other hand CureVac NV has an analysts' consensus of $5.31 which suggests that it could grow by 17.77%. Given that CureVac NV has higher upside potential than FamiCord AG, analysts believe CureVac NV is more attractive than FamiCord AG.
Company Buy Ratings Hold Ratings Sell Ratings VTIAFFamiCord AG0 0 0 CVACCureVac NV1 3 0 -
Is VTIAF or CVAC More Risky?
FamiCord AG has a beta of 0.475, which suggesting that the stock is 52.494% less volatile than S&P 500. In comparison CureVac NV has a beta of 1.842, suggesting its more volatile than the S&P 500 by 84.205%.
-
Which is a Better Dividend Stock VTIAF or CVAC?
FamiCord AG has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CureVac NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. FamiCord AG pays 0.02% of its earnings as a dividend. CureVac NV pays out -- of its earnings as a dividend. FamiCord AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios VTIAF or CVAC?
FamiCord AG quarterly revenues are $26.6M, which are smaller than CureVac NV quarterly revenues of $63.3M. FamiCord AG's net income of $1.4M is lower than CureVac NV's net income of $319.3M. Notably, FamiCord AG's price-to-earnings ratio is 39.49x while CureVac NV's PE ratio is 6.33x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for FamiCord AG is 1.14x versus 12.56x for CureVac NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income VTIAFFamiCord AG1.14x 39.49x $26.6M $1.4M CVACCureVac NV12.56x 6.33x $63.3M $319.3M
-
Which has Higher Returns VTIAF or EVO?
Evotec SE has a net margin of 5.38% compared to FamiCord AG's net margin of -26.29%. FamiCord AG's return on equity of -62.13% beat Evotec SE's return on equity of -17.7%.
Company Gross Margin Earnings Per Share Invested Capital VTIAFFamiCord AG42.89% $0.08 $37.1M EVOEvotec SE-0.04% -$0.14 $1.5B -
What do Analysts Say About VTIAF or EVO?
FamiCord AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Evotec SE has an analysts' consensus of $5.4436 which suggests that it could grow by 77.41%. Given that Evotec SE has higher upside potential than FamiCord AG, analysts believe Evotec SE is more attractive than FamiCord AG.
Company Buy Ratings Hold Ratings Sell Ratings VTIAFFamiCord AG0 0 0 EVOEvotec SE1 0 0 -
Is VTIAF or EVO More Risky?
FamiCord AG has a beta of 0.475, which suggesting that the stock is 52.494% less volatile than S&P 500. In comparison Evotec SE has a beta of 1.783, suggesting its more volatile than the S&P 500 by 78.343%.
-
Which is a Better Dividend Stock VTIAF or EVO?
FamiCord AG has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Evotec SE offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. FamiCord AG pays 0.02% of its earnings as a dividend. Evotec SE pays out -- of its earnings as a dividend. FamiCord AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios VTIAF or EVO?
FamiCord AG quarterly revenues are $26.6M, which are smaller than Evotec SE quarterly revenues of $191.5M. FamiCord AG's net income of $1.4M is higher than Evotec SE's net income of -$50.3M. Notably, FamiCord AG's price-to-earnings ratio is 39.49x while Evotec SE's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for FamiCord AG is 1.14x versus 1.31x for Evotec SE. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income VTIAFFamiCord AG1.14x 39.49x $26.6M $1.4M EVOEvotec SE1.31x -- $191.5M -$50.3M
-
Which has Higher Returns VTIAF or IFRX?
InflaRx NV has a net margin of 5.38% compared to FamiCord AG's net margin of -51538.49%. FamiCord AG's return on equity of -62.13% beat InflaRx NV's return on equity of -82.01%.
Company Gross Margin Earnings Per Share Invested Capital VTIAFFamiCord AG42.89% $0.08 $37.1M IFRXInflaRx NV-320.86% -$0.21 $54.4M -
What do Analysts Say About VTIAF or IFRX?
FamiCord AG has a consensus price target of --, signalling downside risk potential of --. On the other hand InflaRx NV has an analysts' consensus of $11.25 which suggests that it could grow by 1013.96%. Given that InflaRx NV has higher upside potential than FamiCord AG, analysts believe InflaRx NV is more attractive than FamiCord AG.
Company Buy Ratings Hold Ratings Sell Ratings VTIAFFamiCord AG0 0 0 IFRXInflaRx NV5 2 0 -
Is VTIAF or IFRX More Risky?
FamiCord AG has a beta of 0.475, which suggesting that the stock is 52.494% less volatile than S&P 500. In comparison InflaRx NV has a beta of 1.443, suggesting its more volatile than the S&P 500 by 44.312%.
-
Which is a Better Dividend Stock VTIAF or IFRX?
FamiCord AG has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InflaRx NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. FamiCord AG pays 0.02% of its earnings as a dividend. InflaRx NV pays out -- of its earnings as a dividend. FamiCord AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios VTIAF or IFRX?
FamiCord AG quarterly revenues are $26.6M, which are larger than InflaRx NV quarterly revenues of $27.8K. FamiCord AG's net income of $1.4M is higher than InflaRx NV's net income of -$14.3M. Notably, FamiCord AG's price-to-earnings ratio is 39.49x while InflaRx NV's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for FamiCord AG is 1.14x versus 312.07x for InflaRx NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income VTIAFFamiCord AG1.14x 39.49x $26.6M $1.4M IFRXInflaRx NV312.07x -- $27.8K -$14.3M
-
Which has Higher Returns VTIAF or IMTX?
Immatics NV has a net margin of 5.38% compared to FamiCord AG's net margin of -974.45%. FamiCord AG's return on equity of -62.13% beat Immatics NV's return on equity of -25.21%.
Company Gross Margin Earnings Per Share Invested Capital VTIAFFamiCord AG42.89% $0.08 $37.1M IMTXImmatics NV-- -$0.49 $508.8M -
What do Analysts Say About VTIAF or IMTX?
FamiCord AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Immatics NV has an analysts' consensus of $18.75 which suggests that it could grow by 78.57%. Given that Immatics NV has higher upside potential than FamiCord AG, analysts believe Immatics NV is more attractive than FamiCord AG.
Company Buy Ratings Hold Ratings Sell Ratings VTIAFFamiCord AG0 0 0 IMTXImmatics NV9 0 0 -
Is VTIAF or IMTX More Risky?
FamiCord AG has a beta of 0.475, which suggesting that the stock is 52.494% less volatile than S&P 500. In comparison Immatics NV has a beta of 1.360, suggesting its more volatile than the S&P 500 by 35.986%.
-
Which is a Better Dividend Stock VTIAF or IMTX?
FamiCord AG has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Immatics NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. FamiCord AG pays 0.02% of its earnings as a dividend. Immatics NV pays out -- of its earnings as a dividend. FamiCord AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios VTIAF or IMTX?
FamiCord AG quarterly revenues are $26.6M, which are larger than Immatics NV quarterly revenues of $6.1M. FamiCord AG's net income of $1.4M is higher than Immatics NV's net income of -$59.1M. Notably, FamiCord AG's price-to-earnings ratio is 39.49x while Immatics NV's PE ratio is 42.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for FamiCord AG is 1.14x versus 14.03x for Immatics NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income VTIAFFamiCord AG1.14x 39.49x $26.6M $1.4M IMTXImmatics NV14.03x 42.21x $6.1M -$59.1M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 2
Corcept Therapeutics, Inc. [CORT] is up 8.51% over the past day.
Buy
75
AXSM alert for Jan 2
Axsome Therapeutics, Inc. [AXSM] is down 2.33% over the past day.
Sell
50
NUTX alert for Jan 2
Nutex Health, Inc. [NUTX] is down 9.22% over the past day.
